http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107200734-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
| filingDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107200734-B |
| titleOfInvention | Quinuclidine derivative and preparation method and application thereof |
| abstract | The invention relates to quinuclidine derivatives, pharmaceutically acceptable salts, prodrugs and solvent compounds thereof, a preparation method thereof, a pharmaceutical composition containing the same and pharmaceutical application thereof. The compound of the invention has better M3 receptor antagonist activity and can be used as a novel efficient medicine for treating chronic obstructive pulmonary disease. |
| priorityDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.